Glucose‐lowering medications and the risk of cancer: A methodological review of studies based on real‐world data
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glucose‐lowering medications and the risk of cancer: A methodological review of studies based on real‐world data
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-05-07
DOI
10.1111/dom.13766
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records
- (2018) Elisabetta Patorno et al. DIABETES OBESITY & METABOLISM
- Three risk of bias tools lead to opposite conclusions in observational research synthesis
- (2018) Josep-Maria Losilla et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Examining Bias in Studies of Statin Treatment and Survival in Patients With Cancer
- (2018) Louise Emilsson et al. JAMA Oncology
- Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness
- (2018) Jacqueline Corrigan-Curay et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin to Treat Cancer
- (2017) Samy Suissa EPIDEMIOLOGY
- Per-Protocol Analyses of Pragmatic Trials
- (2017) Miguel A. Hernán et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies
- (2016) Jennifer W. Wu et al. DIABETES CARE
- Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE)
- (2015) DIABETES CARE
- Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
- (2014) C M Booth et al. BRITISH JOURNAL OF CANCER
- Metformin and Cancer: Mounting Evidence Against an Association: Figure 1
- (2014) Samy Suissa et al. DIABETES CARE
- The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia
- (2014) Louise Bordeleau et al. DIABETES CARE
- Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations
- (2014) Elisabetta Patorno et al. DIABETOLOGIA
- Propensity Score Methods for Confounding Control in Nonexperimental Research
- (2013) M. Alan Brookhart et al.
- Use of Antidiabetic Agents and the Risk of Pancreatic Cancer: A Case–Control Analysis
- (2012) Michael Bodmer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- Long-term effects of insulin glargine on the risk of breast cancer
- (2011) S. Suissa et al. DIABETOLOGIA
- Time-window Bias in Case-control Studies
- (2011) Samy Suissa et al. EPIDEMIOLOGY
- Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
- (2010) E. Mannucci et al. DIABETES CARE
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Diabetes therapy and cancer risk: causal effects and other plausible explanations
- (2010) S. Hernández-Díaz et al. DIABETOLOGIA
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
- (2009) L. G. Hemkens et al. DIABETOLOGIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search